每經AI快訊，香雪(xue)(xue)制(zhi)藥(yao)（SZ 300147，收盤價：6.8元(yuan)）11月28日晚間發布公(gong)(gong)(gong)(gong)(gong)告(gao)稱，為進一步聚焦(jiao)主營(ying)業務的(de)發展，整合優化資產(chan)結構及資源(yuan)配置，提高(gao)資產(chan)流動(dong)性及使用效(xiao)率，廣州市香雪(xue)(xue)制(zhi)藥(yao)股(gu)份(fen)有限公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)子(zi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)廣東恒頤(yi)(yi)醫(yi)療(liao)有限公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)與信(xin)宜民安房地產(chan)開發有限公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)及擔(dan)保方李(li)煒健、梁程煜、茂(mao)名恒頤(yi)(yi)投資有限公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)簽署了《項目轉(zhuan)讓(rang)協議》，通過股(gu)權轉(zhuan)讓(rang)的(de)方式(shi)將子(zi)公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)茂(mao)名恒頤(yi)(yi)投資有限公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)100%股(gu)權轉(zhuan)讓(rang)給信(xin)宜公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)，交易總對價1.8億元(yuan)：其中股(gu)權轉(zhuan)讓(rang)款5136萬(wan)元(yuan)，茂(mao)名恒頤(yi)(yi)應(ying)向母公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)廣東恒頤(yi)(yi)醫(yi)療(liao)有限公(gong)(gong)(gong)(gong)(gong)司(si)(si)(si)支(zhi)付的(de)股(gu)東借款約1.29億元(yuan)。

2022年(nian)1至6月份，香(xiang)雪(xue)制藥的營(ying)業收入(ru)構成為：中藥材占(zhan)比44.78%，醫(yi)藥流通占(zhan)比30.29%，醫(yi)藥制造占(zhan)比14.47%。

香(xiang)雪制(zhi)藥的董事(shi)長、總(zong)經理均是王永輝，男，60歲，學歷背景(jing)為(wei)碩士。

截至(zhi)發稿，香雪制藥市值為45億(yi)元。

道達號（daoda1997）“個股趨(qu)勢(shi)”提(ti)醒：
1. 香雪制藥近30日內北向資金持股量未發生變化；
2. 近30日內無機構對香雪制藥進行調研。
更多個股趨勢信息(xi)，請搜索微信公眾號(hao)“道達(da)號(hao)”，回復“查詢(xun)”，領(ling)取免費查詢(xun)權限(xian)！

每經(jing)頭條(tiao)（nbdtoutiao）——

(記者 蔡鼎)

免責聲(sheng)明(ming)：本文內容與數據僅供參考，不構(gou)成投資建議，使用(yong)前請核實。據此操作，風險自(zi)擔。